Ionis Pharmaceuticals (IONS) PT Lowered to $55 at BofA Securities
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $45.57 +2.40%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $56.00) while maintaining a Buy rating.
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Lineage Inc (LINE) PT Lowered to $48 at Goldman Sachs
- AppFolio (APPF) PT Raised to $240 at DA Davidson on Strong Growth Profile
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
